BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24500040)

  • 1. Access to treatment for opioid dependence in rural America: challenges and future directions.
    Sigmon SC
    JAMA Psychiatry; 2014 Apr; 71(4):359-60. PubMed ID: 24500040
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone.
    Stein BD; Gordon AJ; Sorbero M; Dick AW; Schuster J; Farmer C
    Drug Alcohol Depend; 2012 Jun; 123(1-3):72-8. PubMed ID: 22093488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

  • 4. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of opioid dependence in the setting of pregnancy.
    Young JL; Martin PR
    Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In control?: Ukrainian opiate substitution treatment patients strive for a voice in their treatment.
    Golovanevskaya M; Vlasenko L; Saucier R
    Subst Use Misuse; 2012 Apr; 47(5):511-21. PubMed ID: 22428819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
    Trigg BG; Dickman SL
    Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR; Lintzeris N; Lea T
    Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome.
    Meyer M; Benvenuto A; Howard D; Johnston A; Plante D; Metayer J; Mandell T
    J Addict Med; 2012 Jun; 6(2):124-30. PubMed ID: 22517450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Rural Access to Opioid Treatment Programs.
    Johnson Q; Mund B; Joudrey PJ
    J Law Med Ethics; 2018 Jun; 46(2):437-439. PubMed ID: 30146991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns in admission delays to outpatient methadone treatment in the United States.
    Gryczynski J; Schwartz RP; Salkever DS; Mitchell SG; Jaffe JH
    J Subst Abuse Treat; 2011 Dec; 41(4):431-9. PubMed ID: 21821378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.
    Jones CM; Campopiano M; Baldwin G; McCance-Katz E
    Am J Public Health; 2015 Aug; 105(8):e55-63. PubMed ID: 26066931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
    Yang JC; Roman-Urrestarazu A; Brayne C
    PLoS One; 2020; 15(3):e0229787. PubMed ID: 32126120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding access to buprenorphine treatment in rural areas with the use of telemedicine.
    Weintraub E; Greenblatt AD; Chang J; Himelhoch S; Welsh C
    Am J Addict; 2018 Dec; 27(8):612-617. PubMed ID: 30265425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid dependence - management in general practice.
    Frei M
    Aust Fam Physician; 2010 Aug; 39(8):548-52. PubMed ID: 20877747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive response to the opioid epidemic: Hazelden's approach.
    Seppala MD
    Minn Med; 2013 Mar; 96(3):45-7. PubMed ID: 23930470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Better efficacy of buprenorphine and methadone in opioid dependence. Requirements for abstinence from non-opioids before starting treatment paid off].
    Hoffmann O; Frisell F; Ljungberg T
    Lakartidningen; 2014 Jan 29-Feb 4; 111(5):147-9. PubMed ID: 24624763
    [No Abstract]   [Full Text] [Related]  

  • 19. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatment of opioid dependence: continued progress and ongoing challenges.
    O'Connor PG
    JAMA; 2010 Oct; 304(14):1612-4. PubMed ID: 20940391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.